Four years on finasteride (1 mg daily) and minoxidil (two years topical, two years oral) from age 24 (top) to 28 (bottom). Looks like I lost a bit of ground Progress Pictures 3/19/2024
The user shared progress pictures after using finasteride and minoxidil for hair loss over four years. Responses vary, with some seeing stabilization or slight improvement, and others noticing a small amount of hair loss.
View this post in the Community β
Similar Community Posts Join
6 / 6 resultscommunity 31M. Just diagnosed with androgenic alopecia. Fears of min.
A 31-year-old man with androgenic alopecia is considering treatments like finasteride, minoxidil, and ketoconazole shampoo but is worried about finasteride's side effects. Users recommend starting with finasteride or dutasteride for DHT blocking, suggesting topical solutions to reduce side effects.
community Finasteride success for androgenic alopecia by a 27M physician (NO PICTURES)
A 27-year-old male physician improved hair density using minoxidil 5% foam and finasteride 1mg every other day, with initial sexual side effects that subsided. He recommends trying finasteride for a year but warns against dutasteride due to potential liver effects.
community DHT Harms Scalp Microbiome: DHT Itch is REAL
Increased Malassezia and Cutibacterium in the scalp microbiome are linked to higher sebum production and inflammation in androgenetic alopecia (AGA). Treatments include ciclopirox shampoo, benzoyl peroxide shampoo, clobetasol propionate, calcipotriol, minoxidil, finasteride, and dutasteride.
community 21M with Temple Hair Thinning: Is My 5% Minoxidil + 0.1% Finasteride + Dutasteride Prescription Normal?
A 21-year-old male experiencing hair thinning and shedding was diagnosed with androgenetic alopecia and prescribed a topical solution containing 5% minoxidil and 0.1% finasteride, multivitamins, and 0.5mg dutasteride daily. He seeks confirmation on whether this prescription is typical for his condition.
community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders
Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.
community I'm 19 years old I've been using finasteride for 2 months and then switched to dutasteride I've been using dutasteride 22 days and I use minoxidil for 1.5 months and add tretitoin
A 19-year-old switched from finasteride to dutasteride after two months due to aggressive androgen alopecia and is also using minoxidil and tretinoin. Users advise patience, caution with dutasteride at a young age, and suggest consulting a doctor.
Related Research
6 / 6 resultsresearch Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia
In this study, the authors reported that oral dutasteride at 0.5 mg/day showed a probable greater efficacy in treating male androgenetic alopecia compared to finasteride and minoxidil, but it may cause sexual dysfunction and neuropsychiatric side effects.
research Finasteride in androgenetic alopecia in men
This article discusses androgenetic alopecia in men and reports that finasteride at 1 mg/day for 24 months is generally well tolerated and may effectively inhibit hair loss.
research Retrospective Pharmacotherapeutic Evaluation of Dutasteride not Approved by US FDA for Androgenetic Alopecia in Korea
In this study, topical minoxidil 7% with dutasteride 0.5 mg showed higher efficacy but more adverse effects compared to minoxidil 7% with finasteride 1 mg for treating androgenetic alopecia.
research Nanotechnology-based topical treatments for androgenic alopecia
This abstract introduces androgenic alopecia as the most common form of non-cicatricial alopecia, which predominantly affects men but also has a significant occurrence in women; however, specific research results or conclusions about treatments or mechanisms are not reported in the summary.
research Androgenetic alopecia: An update
This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.
research Androgenetic Alopecia: a Review and Emerging Treatments
This review covers the pathogenesis, diagnosis, and potential new treatments for androgenetic alopecia but reports no new clinical findings, highlighting an ongoing need for effective therapies.